Nitric Oxide Transport in Blood: A Third Gas in the Respiratory Cycle

被引:58
作者
Doctor, Allan [1 ,2 ]
Stamler, Jonathan S. [3 ,4 ]
机构
[1] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Biochem, St Louis, MO 63110 USA
[3] Case Western Reserve Univ, Cleveland, OH 44106 USA
[4] Univ Hosp Cleveland, Inst Transformat Mol Med, Cleveland, OH 44106 USA
关键词
HYPOXIC PULMONARY VASOCONSTRICTION; ELECTRON-PARAMAGNETIC-RESONANCE; HEME OXYGENASE-1 INDUCTION; ORGAN DYSFUNCTION SYNDROME; ALPHA-NITROSYL HEMOGLOBIN; S-NITROSOTHIOLS SIGNAL; L-ARGININE TRANSPORT; CELL-FREE; RED-CELL; DISTRESS-SYNDROME;
D O I
10.1002/cphy.c090009
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The trapping, processing, and delivery of nitric oxide (NO) bioactivity by red blood cells (RBCs) have emerged as a conserved mechanism through which regional blood flow is linked to biochemical cues of perfusion sufficiency. We present here an expanded paradigm for the human respiratory cycle based on the coordinated transport of three gases: NO, O-2, and CO2. By linking O-2 and NO flux, RBCs couple vessel caliber (and thus blood flow) to O-2 availability in the lung and to O-2 need in the periphery. The elements required for regulated O-2-based signal transduction via controlled NO processing within RBCs are presented herein, including S-nitrosothiol (SNO) synthesis by hemoglobin and O-2-regulated delivery of NO bioactivity (capture, activation, and delivery of NO groups at sites remote from NO synthesis by NO synthase). The role of NO transport in the respiratory cycle at molecular, microcirculatory, and system levels is reviewed. We elucidate the mechanism through which regulated NO transport in blood supports O-2 homeostasis, not only through adaptive regulation of regional systemic blood flow but also by optimizing ventilation-perfusion matching in the lung. Furthermore, we discuss the role of NO transport in the central control of breathing and in baroreceptor control of blood pressure, which subserve O-2 supply to tissue. Additionally, malfunctions of this transport and signaling system that are implicated in a wide array of human pathophysiologies are described. Understanding the (dys)function of NO processing in blood is a prerequisite for the development of novel therapies that target the vasoactive capacities of RBCs. (C) 2011 American Physiological Society. Compr Physiol 1:541-568, 2011.
引用
收藏
页码:541 / 568
页数:28
相关论文
共 317 条